Article
Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism.
American journal of human genetics - 1 May 1991
Gaedigk A, Blum M, Gaedigk R, Eichelbaum M, Meyer U A
Abstract excerpt
The debrisoquine/sparteine polymorphism is associated with a clinically important genetic deficiency of oxidative drug metabolism. From 5% to 10% of Caucasians designated as poor metabolizers (PMs) of the debrisoquine/sparteine polymorphism have a severely impaired capacity to metabolize more than 25 therapeutically used drugs. The impaired drug metabolism in PMs is due to the absence of cytochrome P450IID6...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
